Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Baby formula study: new blends may improve digestion

NCT ID NCT02031003

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study looked at how two new infant formulas—one with a special fat blend and one with added fiber—affect stool composition and digestion in healthy babies. Researchers compared these formulas to standard formula and breast milk in 220 infants in Taiwan. The goal was to see if the new formulas could make stool more like that of breastfed babies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Infant formula with high 2-palmitic vegetable oil or added oligofructose
What this could lead to
If successful, this could help improve infant formulas to better match breast milk's digestive benefits.
What could go wrong
This is a small, completed study focused on stool composition, not on long-term health outcomes. Results may not apply to all babies or formulas.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

220 people

The number who actually took part.

Start date

Sep 2010

Finished

Dec 2011

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 45 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy, term (no less than 37 weeks and no greater than 42 weeks) singleton infants; between 25 days to 45 days post natal age (date of birth = Day 0) and weight for age ≥3rd and ≤97th percentiles according to Taiwan growth charts at the time of study entry. * Human milk fed infants were exclusively consuming and tolerating HM and the mother must have made the decision to continue to exclusively breastfeed. * Formula-fed infants were exclusively consuming and tolerating a cow's milk infant formula and parents/LAR must have previously made the decision to continue to exclusively formula feed. Exclusion Criteria: * Infants receiving any amount of supplemental HM with infant formula feeding or vice versa * Family history of siblings with documented cow's milk protein intolerance/allergy * Major congenital malformations, suspected or documented systemic or congenital infections, evidence systemic diseases

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bottle feeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Bottle Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chang Gung Medical Foundation - LinKou Branch

    Linkou District, Tao-Yuan County, Taiwan

  • Chang Gung Medical Foundation, Taipei Branch

    Taipei, Taiwan

  • Mackay Memorial Hospital

    Taipei, Taiwan

  • Mackay Memorial Hospital - Hsinchu Branch

    Hsinchu, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.